Cell2B is a biotechnology company that develops advanced cellular therapies for its patients. Its aim is to deliver a set of therapies to patients and caregivers to tackle immune, inflammatory, and oncological malignancies.

Cell2B develops new proprietary techniques and protocols to increase their numbers and effectiveness in tissue and organ